This observation has not been described previously; however, Paccagnella et al provided a potential explanation in his investigation of the bone marrow myeloid precursor proliferative activity in patients with lung cancer treated with chemotherapy and GM-CSF. This evidence concerns the gene CSF2 and lung cancer.